Russell Investments Group, Ltd. Kiniksa Pharmaceuticals, Ltd. Transaction History

Russell Investments Group, Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$13.62 - $20.2 $283,486 - $420,442	20,814 New	20,814 $361,000
Q1 2023 May 09, 2023	BUY	$10.7 - $15.79 $85,867 - $126,714	8,025 Added 33.98%	31,639 $340,000
Q4 2022 Feb 08, 2023	BUY	$11.42 - $17.05 $37,149 - $55,463	3,253 Added 15.98%	23,614 $353,000
Q3 2022 Nov 04, 2022	BUY	$9.76 - $13.41 $198,723 - $273,041	20,361 New	20,361 $261,000
Q1 2022 May 05, 2022	SELL	$9.3 - $12.37 $99,882 - $132,853	-10,740 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$10.39 - $15.15 $38,432 - $56,039	-3,699 Reduced 25.62%	10,740 $126,000
Q3 2021 Nov 08, 2021	SELL	$11.39 - $16.23 $2,847 - $4,057	-250 Reduced 1.7%	14,439 $163,000
Q2 2021 Aug 04, 2021	SELL	$13.22 - $19.09 $17,556 - $25,351	-1,328 Reduced 8.29%	14,689 $204,000
Q1 2021 May 10, 2021	BUY	$16.68 - $23.97 $230,467 - $331,193	13,817 Added 628.05%	16,017 $296,000
Q1 2020 May 06, 2020	BUY	$11.0 - $19.76 $24,200 - $43,472	2,200 New	2,200 $34,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $690M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.